3 Biotech Companies Ripe for a Takeover
Motley Fool
This Week in Biotech
Motley Fool
Sarepta Therapeutics: Irrational Exuberance
Seeking Alpha
Will The Big Pharmaceuticals Fall Off A Patent Cliff?
Seeking Alpha
Quickly Approaching Biopharma Catalyst Events
Seeking Alpha
Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval
Seeking Alpha
3 Giant Drug Earnings Wed.: Glaxo, Lilly, Novartis
Investors.com

